Document Detail

Accidental ten times overdose administration of recombinant human erythropoietin (rh-EPO) up to 318,000 units a day in acute myocardial infarction: report of two cases.
MedLine Citation:
PMID:  16445599     Owner:  NLM     Status:  MEDLINE    
The cytokine erythropoietin protects the heart from ischaemic injury, in part by preventing apoptosis. But appropriate dose of erythropoietin for the protection of injured heart has not been studied. While we were researching the cardiac protective effects of erythropoietin in acute myocardial infarction, we experienced two cases of accidental nearly ten times overdose administration of erythropoietin up to 318,000 units instead of 33,000 units on the second day of three scheduled days of treatment. So a total of 384,000 units of erythropoietin were administered during three days. In case 1, the ALT level soared up to 386 U/l on the second day of administration and decreased slowly. It was back to normal state 3 months later. The AST level increased slowly up to 391 U/l and normalized 3 months later. Haemoglobin level was elevated up to 15.7 g/dl (14.7 g/dl at admission) and, 3 months later, normalized to 14.8 g/dl. In case 2, the ALT level was elevated up to 98 U/l on the second day of administration and decreased slowly. Three months later, the ALT level was normalized. The AST level also increased slowly up to 71 U/l and normalized 3 months later. Haemoglobin level was elevated up to 15.6 g/dl (13.8 g/dl at admission) and, 3 months later, normalized to 13.6 g/dl. In these two cases reported, these patients, even after massive overdose, tolerated it relatively well and the only side-effects we found were elevated liver enzyme and haemoglobin levels.
Dae-Hee Shin; Young-Il Kwon; Sung-Il Choi; Ui-Soon Park; Je Lee; Jin-Ho Shin; Jae-Ung Lee; Soon-Gil Kim; Jeong-Hyun Kim; Heon-Kil Lim; Bang-Hun Lee; Kyung-Soo Kim
Related Documents :
6614189 - Evaluation of methods for estimating infarct size by myosin lc2: comparison with cardia...
12470829 - Serum levels of the senescence biomarker clusterin/apolipoprotein j increase significan...
7105799 - The arrhythmic danger of hypokalaemia.
1306419 - Endogenous digitalis-like factor in patients with acute myocardial infarction.
881749 - Dopamine-beta-hydroxylase activity after acute myocardial infarction.
3224449 - Morbidity during five years after myocardial infarction and its relation to infarct size.
3567459 - Effects of morphine on cardiovascular responses to acute myocardial ischaemia in rats.
8417059 - Coronary sinus sampling of cytokines after heart transplantation: evidence for macropha...
15243769 - Postcardiac injury syndrome following radiofrequeny ablation of atrial flutter.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Basic & clinical pharmacology & toxicology     Volume:  98     ISSN:  1742-7835     ISO Abbreviation:  Basic Clin. Pharmacol. Toxicol.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-01-31     Completed Date:  2006-07-07     Revised Date:  2006-10-30    
Medline Journal Info:
Nlm Unique ID:  101208422     Medline TA:  Basic Clin Pharmacol Toxicol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  222-4     Citation Subset:  IM    
Cardiology Division, Hanyang University College of Medicine, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alanine Transaminase / blood
Aspartate Aminotransferases / blood
Erythropoietin, Recombinant / adverse effects*,  therapeutic use
Hemoglobins / analysis
Liver / drug effects,  enzymology
Middle Aged
Myocardial Infarction / drug therapy*,  enzymology
Reg. No./Substance:
0/Erythropoietin, Recombinant; 0/Hemoglobins; EC Aminotransferases; EC Transaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pain perception after subcutaneous injections of media containing different buffers.
Next Document:  Contrasting changes in phase I and phase II metabolism of acetaminophen in male mice pretreated with...